BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Drug Development

  Portola Pharmaceuticals, Inc. Begins Enrollment In Phase 3 Study Of FDA-Designated Breakthrough Therapy Andexanet Alfa And Factor Xa Inhibitor XARELTO®

  May 12, 2014

   · 

  1 min read
• Business

  AC Immune SA And Piramal Imaging Announce Out-Licensing Agreement For The Development Of Tau Protein Diagnostics In Alzheimer’s Disease

  May 12, 2014

   · 

  8 min read
• Pharm Country

  Bristol-Myers Squibb Company To Present At UBS Global Healthcare Conference

  May 12, 2014

   · 

  1 min read
• DBV Technologies To Host And Webcast Investor Day In New York City On May 21, 2014

  May 12, 2014

   · 

  1 min read
• Business

  AntriaBio Establishes Manufacturing And Laboratory Facility In Colorado

  May 12, 2014

   · 

  3 min read
• Pluristem Therapeutics To Present At World Stem Cells Regenerative Medicine Congress 2014 In London

  May 12, 2014

   · 

  1 min read
• BioMidwest

  Array BioPharma, Inc. To Present At The Bank of America Merrill Lynch Healthcare Conference and the UBS Global Healthcare Conference

  May 12, 2014

   · 

  1 min read
• Pharm Country

  Retrophin, LLC Initiates Global Access For RE-024 In Pantothenate Kinase-Associated Neurodegeneration (PKAN)

  May 12, 2014

   · 

  1 min read
• Business

  MediWound Completes Recruitment Of Commercial Management Team In Europe

  May 12, 2014

   · 

  8 min read
• FDA

  Foundation Medicine, Inc. Receives CE Mark; Appoints New Vice President

  May 12, 2014

   · 

  8 min read